Asia Pacific Electrocardiograph Market Report to 2031 - Players Include Abbott Laboratories, ACS Diagnostics, Biotricity and Edan Instruments Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 28, 2022--

The "Asia Pacific Electrocardiograph Market 2021-2031 by Product Type, Lead Type, Function, Technology, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific electrocardiograph (ECG) market will grow by 8.2% annually with a total addressable market cap of $32,834.0 million over 2022-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure.

This report is based on a comprehensive research of the entire Asia Pacific electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Conventional Devices
• Resting ECG Devices
• Stress ECG Devices
• Emerging Devices
• Implantable Loop Recorders
• Mobile Cardiac Telemetry
• Holter Monitors
• Cardiac Event Monitors
• Smart ECG Monitors
• Software & Services

Based on Lead Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Single-Lead Type ECG Devices
• 3-Lead Type ECG Devices
• 5-Lead Type ECG Devices
• 6-Lead Type ECG Devices
• 12-Lead Type ECG Devices
• Other Lead Types

By Function, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Diagnostic ECG Systems
• Monitoring ECG Systems

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Portable ECG Systems
• Wireless ECG Systems

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Home-based Users
• Cardiac Centers
• Other End Users

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($mn) are available for 2021-2031. The breakdown of national markets by Product Type, Lead Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Abbott Laboratories
• ACS Diagnostics
• Biotricity, Inc.
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• CardioComm Solutions, Inc.
• Cardioline SpA
• Edan Instruments, Inc.
• Fukuda Denshi Co., Ltd.
• General Electric Company
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Mindray Medical International Limited
• Nihon Kohden Corporation
• OSI Systems, Inc.
• Schiller AG
• Suzuken Co., Ltd.
• Zoll Medical Corporation (Asahi Kasei Corporation)

For more information about this report visit https://www.researchandmarkets.com/r/ougl8u

View source version on businesswire.com:https://www.businesswire.com/news/home/20221128005296/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES CARDIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.